| |
|
|
|
Cleveland BioLabs Inc.  
|
|
2.21 0.19 (0.09%) |
05-26 09:35 |
|
Open: |
1.98 |
Pre close: |
2.02 |
Target:
|
2.56
|
|
High: |
2.2211 |
Low: |
2.12 |
Resistance:
|
2.20
2.60
|
|
Volume: |
23,447 |
Market Cap: |
25M |
Support:
|
1.54
1.28
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
2.13
 |
MACD |
MACD(12,26):
|
0.10 |
|
MA(20): |
1.87  |
Signal(12,26,9): |
0.06 |
|
MA(100): |
1.92 |
Stochastic Oscillator |
%K(14,3):
|
46.80 |
|
MA(250): |
1.44 |
%D(3): |
53.60 |
|
Average Volume(K) |
3-Month: |
33512
|
52-Week |
High:
|
5.00 |
|
10-Days: |
30532 |
Low: |
0.50 |
|
RSI |
RSI(14):
|
54.20 |
Change(%): |
38.4 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.209 |
Return on Equity (ttm) |
-135.7 |
Shares Out. (M) |
11.40 |
|
EPS Est. Current Year |
-0.160 |
Return on Assets (ttm) |
-44.6 |
Shares Float (M) |
4.06 |
|
EPS Est. Next Year |
-0.480 |
PEG Ratio |
0.00 |
% Held by Insiders |
64.39 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
-21.2 |
% Held by Institutions |
3.68 |
|
Forward EPS |
-0.280 |
Gross Profit (p.s.) |
-0.048 |
Shares Short (K) |
53 |
|
Book Value (p.s.) |
-0.370 |
EBITDA (p.s.) |
-0.175 |
P/E |
-9.67 |
|
Sales Per Share |
0.094 |
Qtrly Earnings Growth |
0.00 |
P/BV |
-5.46 |
|
Profit Margin |
-220.48 |
Operating Cash Flow
(M) |
-2.26 |
P/S |
21.52 |
|
Operating Margin |
-188.05 |
Levered Free Cash Flow
(M) |
-1.45 |
P/CF |
-10.19 |
|
|
|
|
|
|
